Patent details

EP4233850 Title: CAPSULE FORMULATIONS

Basic Information

Publication number:
EP4233850
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP231602715
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CAPSULE FORMULATIONS
French Title of Invention:
FORMULATIONS DE CAPSULES
German Title of Invention:
KAPSELFORMULIERUNGEN
SPC Number:

Dates

Filing date:
27/11/2019
Grant date:
02/10/2024
EP Publication Date:
30/08/2023
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/10/2024
EP B1 Publication Date:
02/10/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
27/11/2039
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/09/2024
 
 

Name:
ChemoCentryx, Inc.
Address:
One Amgen Center Drive, Thousand Oaks, CA 91320, United States (US)

Agent

Name:
NLO
From:
09/12/2024
Address:
P.O. Box 29720, 2502 LS The Hague, Netherlands (NL)
To:

Inventor

1

Name:
LELETI, Manmohan Reddy
Address:
United States (US)

2

Name:
POWERS, Jay P
Address:
United States (US)

Priority

Priority Number:
201862773848 P
Priority Date:
30/11/2018
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/48; A61K 31/451; A61K 47/10; A61K 47/14; A61K 47/40; A61K 47/44; A61P 29/00;

Publication

European Patent Bulletin

Issue number:
202440
Publication date:
02/10/2024
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
01/12/2025
Annual Fee Number:
7
Annual Fee Amount:
82 Euro
Expected Payer:
Last Annual Fee Payment Date:
22/11/2024
Last Annual Fee Paid Number:
6
Last Annual Fee Paid Amount:
66 Euro
Payer:
RWS TRANSLATIONS LTD
Filing date Document type Number of pages
09/12/2024 Power Of Attorney 1
10/12/2024 Outgoing Correspondence 1